16-2084652-G-A
Variant summary
Our verdict is Likely benign. The variant received -1 ACMG points: 2P and 3B. PM2BP4_ModerateBP6
The NM_000548.5(TSC2):c.4430G>A(p.Arg1477Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000138 in 1,447,044 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1477T) has been classified as Uncertain significance.
Frequency
Consequence
NM_000548.5 missense
Scores
Clinical Significance
Conservation
Publications
- tuberous sclerosisInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- tuberous sclerosis 2Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), G2P, Genomics England PanelApp, Ambry Genetics
- lymphangioleiomyomatosisInheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
- tuberous sclerosis complexInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -1 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000548.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TSC2 | NM_000548.5 | MANE Select | c.4430G>A | p.Arg1477Lys | missense | Exon 34 of 42 | NP_000539.2 | ||
| TSC2 | NM_001406663.1 | c.4427G>A | p.Arg1476Lys | missense | Exon 34 of 42 | NP_001393592.1 | |||
| TSC2 | NM_001114382.3 | c.4361G>A | p.Arg1454Lys | missense | Exon 33 of 41 | NP_001107854.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| TSC2 | ENST00000219476.9 | TSL:5 MANE Select | c.4430G>A | p.Arg1477Lys | missense | Exon 34 of 42 | ENSP00000219476.3 | ||
| TSC2 | ENST00000350773.9 | TSL:1 | c.4361G>A | p.Arg1454Lys | missense | Exon 33 of 41 | ENSP00000344383.4 | ||
| TSC2 | ENST00000401874.7 | TSL:1 | c.4229G>A | p.Arg1410Lys | missense | Exon 32 of 40 | ENSP00000384468.2 |
Frequencies
GnomAD3 genomes Cov.: 34
GnomAD2 exomes AF: 0.00000841 AC: 2AN: 237826 AF XY: 0.00000768 show subpopulations
GnomAD4 exome AF: 0.00000138 AC: 2AN: 1447044Hom.: 0 Cov.: 33 AF XY: 0.00000278 AC XY: 2AN XY: 720350 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 34
ClinVar
Submissions by phenotype
Lymphangiomyomatosis;C1846385:Isolated focal cortical dysplasia type II;C1860707:Tuberous sclerosis 2 Uncertain:1
Hereditary cancer-predisposing syndrome Uncertain:1
The c.4430G>A (p.R1477K) alteration is located in exon 34 (coding exon 33) of the TSC2 gene. This alteration results from a G to A substitution at nucleotide position 4430, causing the arginine (R) at amino acid position 1477 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear.
Tuberous sclerosis 2 Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at